Trial
NCT02043587
Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, San Diego
Collaborators
Leadiant Biosciences, Inc.
Condition
Acute Lymphocytic Leukemia
Intervention
DNR
Why stopped
Original investigator for the trial has left
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-02